Press Releases NeuroMetrix, Inc. BOERSE MUENCHEN

Equities

NLZ0

US6412558800

Real-time BOERSE MUENCHEN Other stock markets 05:43:07 2024-06-28 am EDT			5-day change	1st Jan Change
3.48 ^EUR	0.00%		-1.14%	+0.29%

May. 15	NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroMetrix Reports Q1 2024 Business Highlights	May. 15	AQ
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	Apr. 19	AQ
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	Mar. 20	AQ
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	Mar. 14	AQ
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	Mar. 13	AQ
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	Feb. 22	AQ
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	Feb. 15	AQ
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	Feb. 13	AQ
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024	Jan. 08	AQ
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)	Dec. 12	AQ
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy	Dec. 06	AQ
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)	Dec. 05	AQ
NeuroMetrix Announces One-for-Eight Reverse Stock Split	Nov. 20	AQ
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023	23-10-30	AQ
NeuroMetrix Reports Q3 2023 Business Highlights	23-10-26	AQ
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call	23-10-23	AQ
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia	23-10-02	AQ
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023	23-09-28	AQ
NeuroMetrix to Present at the Emerging Growth Conference on September 6, 2023	23-08-30	AQ
NeuroMetrix Reports Q2 2023 Business Highlights	23-07-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NeuroMetrix, Inc. BOERSE MUENCHEN

Equities

NLZ0

US6412558800

Press Releases

Filters